You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,063,771


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,063,771
Title: Formulations for controlling human lice
Abstract:Safer pediculicidal formulations comprising a spinosyn, or a physiologically acceptable derivative or salt thereof, and a physiologically acceptable carrier, and methods of controlling lice infestations in a human with these formulations are provided.
Inventor(s): Snyder; Daniel Earl (Indianapolis, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:09/338,116
Patent Claim Types:
see list of patent claims
Use; Formulation; Composition;
Patent landscape, scope, and claims:

United States Patent 6,063,771: A Detailed Analysis

Introduction

United States Patent 6,063,771, titled "Formulations for controlling human lice," is a significant patent in the field of pharmaceuticals and personal care products. This patent, assigned to Johnson and Johnson Consumer Inc., addresses the formulation and methods for controlling human lice, a common and persistent problem.

Patent Overview

Title and Assignees

The patent is titled "Formulations for controlling human lice" and was assigned to Johnson and Johnson Consumer Inc.[2][4].

Priority and Publication Dates

The priority date for this patent is April 25, 2001, indicating when the initial application was filed. The patent was published and granted subsequently[2].

Claims and Descriptions

Main Claims

The patent primarily focuses on formulations and methods for controlling human lice. The claims include:

  • Hair care formulations such as shampoos, lotions, and conditioners.
  • Methods of using these formulations to kill lice and their eggs[4].

Key Components

The formulations described in the patent often include active ingredients like spinosyn, which is known for its effectiveness against lice. These formulations are designed to be used in various hair care products to ensure comprehensive treatment[4].

Patent Landscape Analysis

Understanding Patent Landscape

Patent landscape analysis is crucial for understanding the broader technological and competitive environment. This analysis involves examining pending and granted patents in a specific field to identify trends, competitors, and potential market entry points[3].

Relevant Patents and Expirations

  • US6063771A: This patent has expired, with its legal status listed as "Expired - Lifetime, expires"[4].
  • Other Related Patents: Other patents related to lice control, such as those held by Cipher Pharmaceuticals Inc. for Natroba, provide insights into the broader patent landscape. For instance, Natroba's patents have various expiration dates, with some already expired and others set to expire in the future[1].

Technical Details

Formulations

The patent describes specific formulations that are effective against human lice. These include:

  • Shampoos
  • Lotions
  • Conditioners These formulations are designed to be easy to use and effective in killing lice and their eggs[4].

Active Ingredients

The primary active ingredient mentioned is spinosyn, a compound known for its insecticidal properties. The use of spinosyn in these formulations is highlighted for its efficacy in controlling lice infestations[4].

Classification and Categories

International Patent Classification (IPC)

The patent is classified under various IPC categories, including:

  • A61K8/00: Cosmetics or similar toiletry preparations
  • A61K8/18: Cosmetics or similar toiletry preparations characterized by the composition
  • A61P33/00: Antiparasitic agents
  • A61P33/14: Ectoparasiticides, e.g., scabicides[4].

Legal Status and Expiry

Current Status

The patent US6063771A has expired. This means that the exclusive rights to the formulations and methods described in the patent are no longer in effect, allowing other companies to develop and market similar products[4].

Impact of Expiry

The expiry of this patent opens up the market for generic or similar formulations. Companies can now develop and sell products that use similar active ingredients and methods without infringing on the original patent.

Market Implications

Competitive Landscape

With the patent expired, the competitive landscape in the lice control market is expected to become more dynamic. Other companies can enter the market with their own versions of lice control formulations, potentially increasing competition and driving innovation[3].

Consumer Benefits

Consumers may benefit from increased competition through lower prices and a wider range of products available in the market.

Strategic Considerations

Patent Search Strategies

For companies looking to enter this market, a thorough patent search strategy is essential. This involves identifying relevant patents, both pending and granted, and understanding their legal status and expected expiry dates[3].

Global Patent Protection

Understanding the global patent landscape is crucial. While US6063771A has expired, similar patents in other countries may still be active, affecting global market entry strategies.

Conclusion

United States Patent 6,063,771 played a significant role in the development of formulations for controlling human lice. With its expiry, the market is now open for new entrants and innovations. Companies must conduct thorough patent landscape analyses to navigate this market effectively.

Key Takeaways

  • Patent Expiry: US6063771A has expired, allowing for generic or similar formulations to enter the market.
  • Formulations and Methods: The patent described hair care formulations and methods for controlling human lice.
  • Active Ingredients: Spinosyn is a key active ingredient in these formulations.
  • Market Implications: The expiry of the patent is expected to increase competition and drive innovation in the lice control market.
  • Strategic Considerations: Companies must conduct thorough patent landscape analyses to navigate the market effectively.

Frequently Asked Questions (FAQs)

1. What is the main focus of United States Patent 6,063,771?

The main focus of this patent is on formulations and methods for controlling human lice, including hair care products like shampoos, lotions, and conditioners.

2. Who was the assignee of this patent?

The assignee of this patent was Johnson and Johnson Consumer Inc.

3. What is the current legal status of this patent?

The patent has expired, meaning the exclusive rights to the described formulations and methods are no longer in effect.

4. What are the implications of this patent's expiry for the market?

The expiry of this patent opens the market for generic or similar formulations, potentially increasing competition and driving innovation in the lice control market.

5. What is the significance of spinosyn in the context of this patent?

Spinosyn is an active ingredient mentioned in the patent for its effectiveness in controlling human lice infestations.

Cited Sources:

  1. Pharsight: Natroba patent expiration.
  2. Unified Patents Portal: US-6063771-A.
  3. Sagacious Research: Navigating Technological Domains with Patent Landscape Analysis.
  4. Google Patents: US6063771A - Formulations for controlling human lice.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,063,771

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,063,771

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 326212 ⤷  Subscribe
Australia 4700499 ⤷  Subscribe
Australia 750046 ⤷  Subscribe
Brazil 9911795 ⤷  Subscribe
Canada 2337789 ⤷  Subscribe
China 1129430 ⤷  Subscribe
China 1314812 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.